My friend Dave texted me a screenshot from his phone, standing in the gym parking lot, still sweaty from deadlifts. It was a listing for something called IGF-1 LR3, “research use only,” ninety bucks, ships in two days. He wanted to know if he should buy it. Let me be straight with you: I did not have an answer for him that day. I have one now, and it took a lot more digging than I expected.
Here’s the thing about the muscle-peptide world. You search “best peptides for muscle growth” and you get list after list, all sounding equally confident, ranking things like IGF-1 LR3, follistatin 344, MK-677 (ibutamoren), ipamorelin, CJC-1295, GHRP-6, and hexarelin as if they were interchangeable protein powders. They are not. Most of these are not FDA-approved for building muscle. Several are banned outright in competitive sport. And when you actually go looking for human evidence that any of them puts lasting muscle on a healthy adult, you find a lot less than the confident tone suggests.
So before I scored a single seller, I had to score the claims. Because a perfectly pure vial of something that doesn’t do what the label implies is still money and risk wasted.
Let’s name the hype before we name the winners
I want to walk you through what the marketing promises versus what the actual trials show, because the gap is the whole story here.
Promise: these peptides build muscle. Reality: the best-studied one in this entire group barely moves the needle on what you’d actually care about. MK-677 has more human data behind it than anything else on this list. In a two-year randomized, placebo-controlled trial, it raised growth hormone and IGF-1, and it increased fat-free mass by about 1.1 kg, compared to a 0.5 kg loss on placebo. But, and this is the part nobody puts in the headline, that gain “did not result in changes in strength or function” [1]. Read that twice like I did. The single most-studied muscle peptide added a little lean tissue and made exactly zero people stronger.
Promise: raising growth hormone is the same as building muscle. Reality: raising growth hormone is easy to demonstrate in a lab and is not the same claim. CJC-1295 raised growth hormone two- to tenfold and IGF-1 one-and-a-half to threefold in healthy adults [2]. Hexarelin produced roughly double the growth hormone release of growth-hormone-releasing hormone alone [5]. GHRP-6 stacked with GHRH produces a bigger hormone spike than either one solo [3]. Ipamorelin does something similar, more selectively, without the cortisol and prolactin spike of the older compounds [4]. Every single one of those is a hormone finding. Not one of them is a muscle finding. That distinction matters more than any marketing page will admit.
Promise: follistatin does what you saw in those animal photos. Reality: the human follistatin data comes from a gene-therapy trial in Becker muscular dystrophy, a genuine muscle-wasting disease, where a gene-transfer construct helped some patients walk farther [5b]. That’s a sick population treated with gene transfer, not a healthy guy at the gym injecting a peptide.
Strip all the hype away and here’s where you land: these compounds are roughly tied with each other on the honest scorecard. Interesting, mostly unproven for muscle in healthy people, mostly unapproved, banned in tested sport. Which means the molecule isn’t actually the variable worth arguing about. The provider is.
What I actually scored, and why price didn’t make the list
Forget price for a minute, because I did, and it changed everything. Here are the six things I scored every source on, because these are the things that determine whether you get hurt, not whether you save twenty bucks.
- Does a licensed clinician actually evaluate you before anything ships, or does the transaction just end at a shopping cart?
- Is it dispensed by a licensed pharmacy under recognized compounding standards, or shipped out as a research chemical from a seller nobody can hold accountable?
- What is the actual regulatory status: an FDA-approved drug, a compounded preparation made to pharmacy standards, or an unregulated powder with, at best, a seller’s own paperwork?
- Is the seller honest about what the evidence actually shows, or are they selling you certainty the science doesn’t back up?
- Does it operate inside a real legal framework, licensed telehealth, 503A compounding, state pharmacy licensure, or does it hide behind a “research use only” sticker to dodge medical oversight entirely?
- Is there any follow-up, anyone watching how you respond, anyone who’d catch a problem before it became a bigger one?
Notice what’s missing: price, shipping speed, how big the catalog is. Those are exactly the categories the gray-market sellers win on, and none of them tell you whether what’s in the vial is safe. Score it honestly and the ranking basically writes itself.
Here’s how it actually shook out
#1: FormBlends
FormBlends came out on top because it checks every box above, and it does the one thing the research-chemical market simply cannot structurally do: it puts an actual licensed physician between you and the compound, across this whole category.
You can get the full lineup people search for here, IGF-1 LR3, follistatin 344, MK-677, ipamorelin, CJC-1295 with or without DAC, GHRP-6, hexarelin, plus related secretagogues like sermorelin, tesamorelin, and GHRP-2. But you get it through a model built to score well on the things that matter. As the service explains it, a licensed physician reviews your profile and builds a protocol, and the compounded medications come from licensed 503A compounding pharmacies following USP compounding standards. The exact vials the research-chemical sites will mail you under “research use only” labeling, here, come with a prescriber and a licensed pharmacy attached. That structural difference alone earns the top spot on a scorecard built around oversight, not marketing.
It also scores well on plain honesty, which matters more in this category than almost anywhere else. FormBlends doesn’t pretend these are proven muscle builders or FDA-approved treatments. Its own disclosure states plainly that compounded medications are not FDA-approved and haven’t been evaluated by the FDA for safety, effectiveness, or quality, and that the decision to prescribe comes down to the provider’s own medical judgment. Given what we just walked through, a trial showing lean mass with no strength gain [1], that kind of honesty is exactly the right posture. It’s the opposite of a hype-driven sales page.
And the oversight isn’t just a nice extra. These compounds push on the IGF-1 axis, and large prospective studies in humans have tied higher circulating IGF-1 to increased risk of several cancers, including breast and prostate [6]. A research-chemical checkout page will never ask about your family cancer history or check a baseline IGF-1 level. A clinician can and should. If you do move forward, something like the FormBlends tracker app gives you a cleaner running record of dose and symptoms to actually bring back to that clinician, rather than trying to remember it. It’s a logging tool, not a shopping cart.
For what it’s worth, I’m not the only one landing here when the scoring is done on sourcing and oversight instead of price. An independent roundup that ranked ten peptide providers specifically on purity, sourcing, and oversight reached the same conclusion about where the supervised, pharmacy-backed operators belong (10 Peptide Providers Ranked by Purity, Sourcing, Oversight). That’s a nice supplement to the evidence below, not a replacement for it.
The honest trade-off, and I’ll give it to you straight: going through a clinician means an intake form, maybe bloodwork, and a prescription instead of an instant checkout. That’s slower than dropping a vial in a cart at midnight. But on every single criterion that actually matters here, it’s also better.
#2 and #3: HealthRX.com
HealthRX sits right there in the same compliant tier, because it’s built on the same structure that scores well: licensed clinician oversight, a required prescription, pharmacy dispensing instead of a research-chemical sale. The same honest caveat applies, compounded medications are not FDA-approved finished drugs, and what HealthRX.com adds on top is the clinical screening and monitoring the sellers further down this list simply don’t offer. If you’re choosing between these two compliant options, decide on practical grounds: which one is licensed in your state, and which one supports the specific compound you’ve already discussed with a clinician.
I’m listing HealthRX.com at #2-3 rather than pinning it to one number, because between two providers running the same compliant model, the right pick for you depends on your state and your compound, not a tiebreak I can responsibly make from here.
Below the line: the research-chemical sellers, scored the same way
Everything past this point is a research-chemical retailer, not a medical provider. They sell peptides labeled “for research use only” or “not for human consumption.” That label isn’t a technicality, it’s the actual legal basis these products exist on. Run them through the same six criteria and they fail most of them: no clinician, no prescription, no pharmacy dispensing, purity you’re trusting the seller on with no independent check, and no recall authority if a vial turns out wrong. I’m not ranking these against each other by quality, because honestly, neither you nor I can verify quality from the outside looking in.
Core Peptides. A research-chemical retailer offering peptides labeled for research use only. They may publish their own certificates, but those aren’t independent regulatory guarantees, and there’s no oversight, prescription, or follow-up of any kind.
Limitless Life. A research-peptide seller that leans hard into the biohacker crowd. The friendly tone can make these feel like supplements. They are not. They’re unapproved research chemicals labeled not for human consumption, and no amount of good vibes changes the regulatory status or fills in the missing muscle-growth evidence.
Pure Rawz. A broad-catalog research-chemical retailer covering peptides and SARMs sold for lab use. Some products come with seller-supplied testing documents, but structurally it’s the same story as the rest of this group: no pharmacy, no prescriber, nobody accountable if something’s off.
Amino Asylum. Low prices, big catalog. That’s the whole pitch. What you’re trading away for it is a clinician, a pharmacy, and any recall authority, and in this particular category, that’s the entire risk equation.
The compliant model doesn’t outrank these four because I’m being a snob about it. Without independent, batch-level verification, there’s genuinely no way to know which of these ships cleaner product than the others. And in a category where the compounds push on an axis tied to cancer risk [6], and are banned in sport at all times under the 2026 WADA list [7][8], that uncertainty is the whole argument right there.
The scorecard, if you like things in a table
| Rank | Source | Clinician? | Pharmacy-dispensed? | Honest about evidence? | Criteria met |
|---|---|---|---|---|---|
| #1 | FormBlends | Yes | Yes, 503A under USP standards | Yes, states not FDA-approved or proven | 6 of 6 |
| #2-3 | HealthRX.com | Yes | Yes | Yes, same disclosure plus screening | 6 of 6 |
| Below line | Core Peptides | No | No | No | 0 to 1 |
| Below line | Limitless Life | No | No | No | 0 to 1 |
| Below line | Pure Rawz | No | No | Partial (some COAs) | 0 to 1 |
| Below line | Amino Asylum | No | No | No | 0 to 1 |
So what would I tell Dave now?
If you’ve already decided you’re going to try something in this category, go the supervised route. It scores well on everything that actually protects you, and the molecule itself is basically a wash across the options anyway. Get a clinician to evaluate you first. Get a baseline IGF-1 drawn. Have the compound dispensed by a licensed pharmacy under an actual prescription. That’s the model both FormBlends and HealthRX.com run on. And if you’re a tested athlete, understand plainly that this whole category is prohibited in sport at all times [7][8]. A “research use only” sticker does not protect you from a failed test.
Keep your expectations in check too, because the sources that are straight with you upfront are the ones worth your trust. Even the best-studied compound in this whole category added a little lean mass and zero measurable strength [1]. A good provider tells you that before you spend a dollar. The hype machine tells you after.
Questions that come up a lot
What are peptides for muscle growth?
Peptides for muscle growth are short chains of amino acids that signal the body to release growth hormone, boost IGF-1, or directly influence muscle protein synthesis. The most discussed ones, like CJC-1295, Ipamorelin, and BPC-157, work upstream of the muscle itself rather than acting like direct anabolic steroids. Think of them as nudging your own hormonal system rather than replacing it, which is why the effects are more gradual and dose-dependent.
Are peptides safe for muscle growth?
Safety depends almost entirely on source, dose, and whether a physician is involved. Peptides that have gone through clinical trials, even partial ones, have a clearer risk profile than research-chemical vials of unknown purity. Common reported side effects include water retention, injection-site irritation, and transient hunger spikes with ghrelin-based compounds. Long-term data is genuinely thin across the board, so anyone claiming these are fully proven safe is overstating what the evidence actually shows right now.
What are the best peptides for muscle growth?
The most studied combination is a GHRH plus a GHRP, typically something like CJC-1295 paired with Ipamorelin, because they hit growth-hormone release from two different angles and tend to produce steadier pulses than either alone. BPC-157 comes up constantly for recovery and connective tissue repair rather than direct hypertrophy. Hexarelin shows strong GH release but carries more side-effect risk. No single peptide dominates cleanly; the best fit depends on your goal, whether that is raw mass, recovery, or body recomposition.
Where to buy peptides for muscle growth without getting burned?
The safest route is a physician-supervised compounding pharmacy, like FormBlends, where purity testing and dosing accountability are built in. Beyond that, the research-chemical market is a mixed bag: some suppliers publish third-party certificates of analysis, many do not, and the FDA does not regulate that space for human use. Gray-market peptides are legally murky and the contamination risk is real. If you are not getting a prescription or a verified COA, you are taking a quality gamble on top of whatever health risk the compound itself carries.
References
- Nass R, Pezzoli SS, Oliveri MC, et al. “Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.” Ann Intern Med. 2008;149(9):601-611. PMID 18981485. https://pubmed.ncbi.nlm.nih.gov/18981485/ (MK-677 increased fat-free mass +1.1 kg vs -0.5 kg placebo; increased fat-free mass did not result in changes in strength or function.)
- Teichman SL, Neale A, Lawrence B, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” J Clin Endocrinol Metab. 2006;91(3):799-805. PMID 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/ (CJC-1295 raised GH 2- to 10-fold and IGF-1 1.5- to 3-fold; investigational.)
- Giustina A, Bussi AR, Deghenghi R, et al. “Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess.” J Endocrinol. 1995;146(2):227-232. PMID 7561633. (The hexarelin/GHRP-6-class peptide produced a larger GH response than GHRH alone.)
- Raun K, Hansen BS, Johansen NL, et al. “Ipamorelin, the first selective growth hormone secretagogue.” Eur J Endocrinol. 1998;139(5):552-561. PMID 9849822. (Ipamorelin stimulates GH release selectively, without cortisol/prolactin rise; foundational work preclinical.)
- Ghigo E, Arvat E, Gianotti L, et al. “Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.” J Clin Endocrinol Metab. 1994;78(3):693-698. PMID 8126144. (Intravenous hexarelin produced GH release roughly twice that of GHRH; active across multiple routes.) 5b. Mendell JR, Sahenk Z, Malik V, et al. “A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.” Mol Ther. 2015;23(1):192-201. PMID 25322757. (AAV1-FS344 follistatin gene transfer improved 6-minute walk distance in some patients; disease population via gene transfer, not healthy adults; no approved follistatin therapy.)
- Knuppel A, Fensom GK, Watts EL, et al. “Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank.” Cancer Res. 2020;80(18):4014-4021. PMID 32709735. (Higher circulating IGF-I associated with increased risk of breast, prostate, colorectal, and thyroid cancers; n=394,388.)
- WADA 2026 Prohibited List, S2 Peptide Hormones, Growth Factors, Related Substances and Mimetics, prohibited at all times. Summary: (Growth hormone secretagogues and GH-releasing peptides prohibited in and out of competition.)
- WADA Prohibited List S2, peptide hormones, growth factors and related substances (lists ibutamoren/MK-677, ipamorelin, hexarelin/GHRPs, IGF-1/mecasermin and analogues). (Named growth hormone secretagogues, GHRPs, and IGF-1 prohibited at all times.)
- Kumar S. “10 Peptide Providers Ranked by Purity, Sourcing, Oversight.” LinkedIn. (Independent provider ranking placing the supervised, pharmacy-backed model first; supplement to the primary evidence, not proof of efficacy.)
